The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引：8
|
作者：
Kaltsas, Gregory [1 ]
Grossman, Ashley B. [2 ]
机构：
[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 06期
关键词：
PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;
D O I：
10.1111/cen.12831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 50 条
  • [21] The role of somatostatin receptor scintigraphy in predicting treatment response of somatostatin analogues in pancreatic neuroendocrine tumors
    Gao, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 134 - 134
  • [22] Somatostatin analogues: treatment of pituitary and neuroendocrine tumors
    Colao, Annamaria
    Faggiano, Antongiulio
    Pivonello, Rosario
    NEUROENDOCRINOLOGY: PATHOLOGICAL SITUATIONS AND DISEASES, 2010, 182 : 281 - 294
  • [23] Radiolabelled somatostatin analogues in the treatment of neuroendocrine cancers
    Handkiewicz-Junak, Daria
    Roszkosz, Jozef
    Hasse-Lazar, Kormelia
    Jurecka-Lubieniecka, Beata
    Krajewska, Jolanta
    Jarzab, Barbara
    ENDOCRINE JOURNAL, 2010, 57 : S585 - S585
  • [24] Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine turnors
    Delaunoit, T
    Rubin, J
    Neczyporenko, F
    Erlichman, C
    Hobday, TJ
    MAYO CLINIC PROCEEDINGS, 2005, 80 (04) : 502 - 506
  • [25] Somatostatin analogues in the treatment of enteropancreatic neuroendocrine tumors
    Sanchez Dominguez, G.
    Jimenez, J. C.
    Sanchez, J. J.
    Correa, R.
    Alegria, J. A.
    Medrano, R.
    Rivera, S.
    Pimentel, A.
    Dip, A. K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 144 - 144
  • [26] Anti-proliferative effect of somatostatin analogues in gastroenteropancreatic neuroendocrine tumours
    Kolasinska-Cwikla, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (05): : 272 - 275
  • [27] Efficacy and safety of use of somatostatin (SS) analogues in metastatic neuroendocrine tumours
    Rodrigues, T. A.
    Quintela, A.
    Costa, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
    Oberg, Kjell
    Lamberts, Steven W. J.
    ENDOCRINE-RELATED CANCER, 2016, 23 (12) : R551 - R566
  • [29] Unlabelled somatostatin analogues in treatment of digestive endocrine tumours
    Panzuto, F
    Nasoni, S
    Baccini, F
    Cassetta, S
    Corleto, VD
    Delle Fave, G
    DIGESTIVE AND LIVER DISEASE, 2004, 36 : S42 - S47
  • [30] Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
    Ambrosini, Valentina
    Zanoni, Lucia
    Filice, Angelina
    Lamberti, Giuseppe
    Argalia, Giulia
    Fortunati, Emilia
    Campana, Davide
    Versari, Annibale
    Fanti, Stefano
    CANCERS, 2022, 14 (04)
12345